1992
DOI: 10.1016/0192-0561(92)90116-3
|View full text |Cite
|
Sign up to set email alerts
|

Methyl inosine monophosphate: A potential immunotherapeutic for early human immunodeficiency virus (HIV) infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1992
1992
1997
1997

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…fMethylinosine monophosphate, a purine derivative prepared from D-ribose, was shown to attenuate HIVinduced immunosuppression (Hadden et al 1992). Modi®ed nucleoside antiviral and anticancer agents, such as neplanocin-A (Hill et al 1994), formycin, pyrazofurin (Rycroft et al 1995), and analoges of their key intermediates (Gallos et al 1994a), have all been enantioselectively synthesized from D-ribose.…”
Section: Applications Of D-ribosementioning
confidence: 99%
“…fMethylinosine monophosphate, a purine derivative prepared from D-ribose, was shown to attenuate HIVinduced immunosuppression (Hadden et al 1992). Modi®ed nucleoside antiviral and anticancer agents, such as neplanocin-A (Hill et al 1994), formycin, pyrazofurin (Rycroft et al 1995), and analoges of their key intermediates (Gallos et al 1994a), have all been enantioselectively synthesized from D-ribose.…”
Section: Applications Of D-ribosementioning
confidence: 99%
“…Methyl inosine monophosphate, a new purine derivative prepared from D-ribose, is under preclinical development, as it attenuates HIV-induced immunosuppression (Hadden et al, 1992). Modified nucleoside antiviral and anticancer agents such as neplanocin-A (Hill et al, 1994), formycin and pyrazofurin (Rycroft et al, 1995), as well as some analogues of their key intermediates (Gallos et al, 1994a), have all been enantioselectively synthesized from D-ribose.…”
Section: Applications Of O-ribosementioning
confidence: 99%